Breast Biopsy Devices Market Size, Share, Growth, and Industry Analysis, By Type (Biopsy Needles, Biopsy Tables, Guidance Systems, Localization Wires), By Application (Hospital, Clinic), and Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

BREAST BIOPSY DEVICES MARKET OVERVIEW

The global breast biopsy devices market size was USD 0.80 billion in 2026 and is projected to touch USD 2.11 billion by 2035, exhibiting a CAGR of 11.4% during the forecast period.

Breast biopsy devices market is one of the fast rising sectors of medical devices sector with heightened awareness and need to detect and diagnose cancer at an early stage. It is anticipated that the market will see a considerable growth because of the rising cases of breast cancer, development of new biopsy technologies, and growth of use of minimally invasive procedures. Few players dominate the market such as Hologic, Bard Medical and Cook Medical which have various varieties of biopsy devices like: vacuum-assisted biopsy needles, core needle biopsy devices and fine needle aspiration biopsy devices.

The products, applications, and geographic segments would be used to segment the breast biopsy devices market. The market is segmented based on the type of products and they include vacuum-assisted biopsy needles, core needle biopsy devices, fine-needle aspiration biopsy devices, and more. The market is divided by application into breast cancer diagnosis, breast lump biopsy and benign breast disease diagnosis. North America, Europe, Asia-Pacific, and Rest of the World are the geographical divisions of the market. The market is likely to be dominated by the North American region and then Europe and Asia-Pacific. The market in the Asia-Pacific would grow because of the increasing demand of breast biopsy devices in the emerging markets, including India and China. The growth of the breast biopsy devices market in the next few years is likely to be induced by the increased use of minimally invasive surgical procedures, the development of cutting-edge biopsy tools, and the rising awareness rate on breast cancer diagnosis.

COVID-19 IMPACT

Breast Biopsy Devices Industry Had a Negative Effect Due to Global Lockdowns and Restrictions during COVID-19 Pandemic.

Covid-19 had a notable impact on the Breast Biopsy Devices market share. The worldwide COVID-19 event has been unprecedented and overwhelming with the market recording the less-than-anticipated demand in all parts of the world compared to the pre-pandemic time. The abrupt expansion of the market as shown by the increase in the CAGR can be explained by the fact that the market started to grow and demand to reach the level before the pandemic.

The coronavirus infection influenced the breast biopsy device market significantly on the global level. First, the pandemic caused the demand of the breast biopsy devices to decrease because an increasing number of healthcare facilities had to focus on emergency and critical healthcare services and did not have time to pay attention to non-essential medical services like biopsies. Moreover, the threat of hospital-acquired infections and the necessity to obey the rules of social distancing made the patient numbers refer to medical care smaller, which led to a decrease in the sales of breast biopsy devices.

Nonetheless, the market of breast biopsy devices was also benefited in the long term due to the pandemic. The awareness and fear of cancer, especially breast cancer, increased and resulted in more women pursuing mammography and subsequent biopsy. Along with that, there was a transition to minimally invasive and precision medicine treatments, including those provided by breast biopsy devices, which was accelerated due to the pandemic when healthcare providers tried to decrease the risk of infection and enhance patient outcomes.

LATEST TRENDS

Minimally invasive procedures to Drive Market Growth

The market of breast biopsy devices is experiencing an increase due to the emergence of the minimally invasive procedures like vacuum assisted breast biopsy systems. These systems enable quicker and less painful processes. They offer more precise diagnosis and have an option of removing many samples of tissues simultaneously. This is likely to be trending because more women are choosing less invasive procedures. Also, the development of the digital imaging technologies also contributes to the market growth. This tendency is likely to boost the breast biopsy devices market within the next years.

•   
•   
  

  Download Free Sample to learn more about this report

    

BREAST BIOPSY DEVICES MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Biopsy Needles, Biopsy Tables, Guidance Systems, Localization Wires.

• Biopsy Needles: Tissue samples are taken by biopsy Needles in the breast and usually directed by images or ultrasound or MRI. They are of various varieties such as vacuum-assisted and fine needle aspiration. These needles are applicable in core and fine needle biopsies.

• Biopsy Tables: The Biopsy Tables offer a stable and comfortable platform on which the breast biopsies can be conducted enabling the medical practitioner to easily manipulate the biopsy machines. Such tables frequently include such built-in functions as adjustable height and angle to suit the various patient positions. They assist in the decrease of fatigue and increase in accuracy.

• Guidance Systems: Guidance Systems help in proper localization and targeting of tumors during the breast biopsies, and may be used alone or in combination with other technologies such as ultrasound, X-ray, and MRI. These devices offer real time imaging and navigation whereby the healthcare professional can accurately control the biopsy needle. They enhance the patient safety and the general accuracy of the diagnosis.

• Localization Wires: Localization Wires Localization wires are fine, slender wires that are used in identifying the site of a tumor or lesion, in cases of breast biopsies, particularly when imaging guided biopsies have been carried out. They are placed beneath the skin and are used as a guide during later surgical operations. These are wires that assist in the planning and overall performance of effective surgeries.

By Application

Based on application, the global market can be categorized into Hospital, Clinic.

• Hospital Application: Breast biopsy devices are employed to define breast cancer in a specific and minimum invasive way in hospitals. The devices empower doctors to obtain tissue samples of the breast to continue with their examination. Hospitals are able to use these devices as an aid to deliver efficient and precise diagnosis to the patients.

• Clinic Application: Breast biopsy machines are also applicable in clinics in the event of minor surgery to diagnose breast cancer. Sometimes, such devices are applied to such procedures as the fine needle aspiration and core needle biopsy. With these devices, clinics are able to offer clients fast and efficient choices of diagnosis and treatment to patients.

MARKET DYNAMICS

Driving Factors

Rising Prevalence of Breast Cancer to Boost the Market

A factor in the Breast Biopsy Devices market growth is the Rising Prevalence of Breast Cancer. Incidence of breast cancer is a contributing factor to the rising market of the breast biopsy devices based on the resultant demand of the diagnostic and treatment options. This has increased the use of the minimally invasive biopsy devices and the use of high-level imaging technology. Consequently, manufacturers are coming up with innovative products in order to meet this increasing demand. Moreover, the aging population and the increase in healthcare systems in the developing economies also make the breast biopsy devices to be highly adopted. This will push the market ahead, as the trend is predicted to persist. This market is also growing due to the need of precision and accuracy in the diagnosis of breast cancer.

Advancements in Technology Enhance Diagnostic Capabilities to Expand the Market

The other important factor that is contributing to the growth of the breast biopsy devices market is the growth in technology as more people are increasingly demanding the need to have the accurate and least invasive diagnostic solutions. The diagnosis capabilities of breast biopsy devices have been enhanced by the development of the advanced imaging technologies, including ultrasound and MRI. There is also the use of robotic-assisted and computer-aided detection (CAD) systems, which are also driving this market. Such technologies can help medical workers to receive high quality images and correct diagnosis, which contributes to the further demand of breast biopsy equipment. The diagnostic capability of the breast biopsy devices is also improving as artificial intelligence and machine learning algorithms are integrated into them. With the ever changing technology, the market of the breast biopsy devices is bound to grow tremendously.

Restraining Factor

High Costs to Potentially Impede Market Growth

The limitation factor concerning the breast biopsy devices market is that the procedures and devices are expensive. This is an expensive burden to patients and health care systems especially in the low-income countries where access to healthcare is already scarce. Another primary issue that hospitals and healthcare facilities should be concerned about is the high price of breast biopsy devices and this could result in the low uptake rates. Also, the price of disposable biopsy needles and other consumables may increase the overall cost. This cost barrier would constrain the growth of the market as the demand of the breast biopsy devices will be low. The entry barrier may also be influenced by the fact that the cost is very high hence deterring new entrants to the market.

Combination of the Artificial Intelligence (AI) and the Machine Learning (ML) to Create Opportunity for the Product in the Market

Opportunity

The combination of the Artificial Intelligence (AI) and the Machine Learning (ML), incorporated in the devices of breast biopsy, is going to transform the sphere. The proposed improved technologies will facilitate the creation of intelligent biopsy machines which have the capability of identifying the abnormal cell patterns and genetic makeup.

This advanced application will revolutionize the market of the breast biopsy machines, making the sector grow and innovate. Possible outcomes are enormous in terms of the ability to provide better treatment and lives, and AI-driven equipment will become the new frontier of breast biopsy technology.

Advancements in Precision Medicine Could Be a Potential Challenge for Consumers

Challenge

The most significant issues that the market of the Breast Biopsy Devices will face in the nearest future will be to create new advanced devices and provide real-time analysis based on AI to reduce the necessity of further surgical intervention. This will involve applying artificial intelligence and machine learning software and high-resolution imaging technologies. The machines must have the capability of detecting cancerous cells and giving specific treatment suggestions to each patient.

Also, the gadgets will require to be made with reduced sizes and enhanced portability to enable their ease of use in different medical environments. In addition, the devices must as well possess high safety measures to avoid any form of complications when the biopsy process is being done. The problem will be to balance accuracy, speed, and safety and reduce costs.

•   
•   
  Download Free Sample to learn more about this report

    

BREAST BIOPSY DEVICES MARKET REGIONAL INSIGHTS

• North America

North America is the fastest-growing region in this market. The United States Breast Biopsy Devices market has been growing exponentially owing to multiple reasons. Breast biopsy equipment market is North America is stimulated by the existence of such major players as Hologic and Biopsys Medical. Development of awareness on breast cancer and increasing demand of the minimally invasive procedures are some of the factors that are growing the market. Nevertheless, the cost of such advanced biopsy devices is too high to take up in the region.

• Europe

The market of the European breast biopsy equipment is characterized by high presence of the established market players and favorable reimbursement situation. Increased breast cancer incidence and the growing use of sophisticated methods of biopsy make the market grow. The tough regulatory environment and expensive devices in the area are a threat to market growth.

• Asia

The market of the Asia Pacific breast biopsy devices will be characterized by fast evolution due to the growing awareness of the disease and the need to use more sophisticated diagnostic methods. Expansion of healthcare facilities and the use of less invasive surgical methods are some of the factors that have contributed to the growth of the market. The high prices of equipment and low reimbursement options are obstacles to the expansion of the market in the emerging economy.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Key industry players are shaping the breast biopsy devices marketplace through strategic innovation and market expansion. These companies are introducing advanced techniques and processes to improve the quality and performance of their offerings. They are also expanding their product lines to include specialized variations, catering to diverse customer preferences. Additionally, they are leveraging digital platforms to increase market reach and enhance distribution efficiency. By investing in research and development, optimizing supply chain operations, and exploring new regional markets, these players are driving growth and setting trends within the breast biopsy devices.

List Of Top Breast Biopsy Devices Companies

• Mammotome [U.S.]
• Hologic [U.S.]
• C. R. Bard [U.S.]
• BD (Becton, Dickinson and Company) [U.S.]
• Stryker [U.S.]

KEY INDUSTRY DEVELOPMENT

August 2022: Mammotome Revolve X2 Dual Vacuum-Assisted Breast Biopsy System is specifically designed with the removal of benign breast lesions, twice as fast as the conventional vacuum-assisted biopsy devices. It has increased specimen collection cup and ergonomic handpiece which increases workflow efficiency and the optional sterile EZ-Sleeve, which improves the hygiene of the procedure. The on-demand variable aperture allows clinician control and optimized patient outcomes by customizing the sampling.

REPORT COVERAGE

SWOT analysis is presented in this work at a high level, and helpful recommendations regarding further evolvement of the market are considered. This paper takes an opportunity to review and discuss the market segments and possible applications that have the potential to influence the market growth in the future years. The breast biopsy devices with better portability is expected to gain high growth rates due to better consumer adoption trends, increasing application areas, and more innovative product developments. Yet, there might be some problems like, for instance, the shortage of raw materials or higher prices for them. However, the growing popularity of specialized offerings and tendencies towards enhancing quality foster the growth of the market. All of them are progressing through technology and innovative strategies in developments as well as in supply chain and market. Due to changes in the market environment and growing demand for variety, the breast biopsy devices has a promising development since it constantly develops and expands its application.